Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apotheca Biosciences is a biopharmaceutical and medical technology company dedicated to developing innovative drug delivery systems and cannabinoid-based therapies. The company focuses on providing non-opioid alternatives for pain management and inflammation by leveraging proprietary transdermal and sublingual delivery technologies. Its portfolio includes the Pro-Steth, a digital stethoscope designed for enhanced cardiac and pulmonary diagnostics, alongside a range of CBD-infused topical formulations and oils. Apotheca Biosciences aims to address the global opioid crisis by offering effective, non-addictive therapeutic solutions for chronic conditions. The company operates primarily in the nutraceutical and pharmaceutical-grade cannabinoid markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apotheca Biosciences.